KBR

Policy Despite government’s refusal to accept resignation, medical professors ‘quietly’... A top government official recently said that professors at even private medical schools, let alone national ones, are subject to the National Civil Service Act, raising the possibi... Kwak Sung-sun 2024-04-23 4:02 PM

Pharma GC Biopharma applies for US approval of Sanfilippo Syndrome treatment GC Biopharma said it has submitted an investigational new drug (IND) application and applied for Fast Track Designation with the U.S. FDA for GC1130A, an intracerebroventricular (I... Lee Han-soo 2024-04-23 3:02 PM

Pharma Pharos iBio and MEDiC to collaborate on new drug research Pharos iBio said it has signed a memorandum of understanding with MEDiC Life Sciences, a Silicon Valley-based company that has established a gene-scissor technology (CRISPR) based ... Yang Hyeon-su 2024-04-23 4:54 PM

Pharma Curocell applies for expedited approval of CAR-T therapy Curocell, a chimeric antigen receptor-T (CAR-T) developer, has applied for Anbal-cel, its CAR-T candidate, to be included in the Ministry of Food and Drug Safety (MFDS)’s Advanced ... Lee Han-soo 2024-04-23 11:00 AM

Bio Jung Kwan Jang hosts seminar on red ginseng at US conference Jung Kwan Jang, Korea’s top ginseng product manufacturer, said it conducted a seminar focused on the efficacy and safety of red ginseng during the International Conference on the S... Lee Han-soo 2024-04-23 3:02 PM

Pharma Celltrion's Remsima attains 74% market share in 5 key European countries Celltrion's Remsima (infliximab) line of products continues to demonstrate market impact with expanded prescriptions in five major European countries—the U.K., Germany, France, Spa... Korea Biomedical Review 2024-04-23 11:51 AM

Device/ICT Kakao Healthcare and OURHOME to research and develop AI-based… Kakao Healthcare said Tuesday that it has signed a business agreement with global food care and catering company OURHOME to develop AI-based ultra-personalized healthcare solutions... Korea Biomedical Review 2024-04-23 11:01 AM

Pharma HK inno.N’s GERD drug K-CAB advances to Middle East, North Africa HK inno.N's GERD drug K-CAB has expanded its momentum to the Middle East and North Africa region.Starting from China and expanding across Asia and North and South America, K-CAB is... Korea Biomedical Review 2024-04-23 11:50 AM

Device/ICT Deep Bio's prostate cancer diagnosis software aims to enter US… The importance of early diagnosis of prostate cancer cannot be overstated. According to data from the World Cancer Research Fund International, prostate cancer is the second most c... Lee Han-soo 2024-04-22 3:13 PM

Pharma MBK Partners to buy pharma distributor Geo-Young for nearly ₩2 trillion: report Korea's largest private equity firm, MBK Partners, has agreed to purchase a majority stake in Geo-Young, the nation's top pharmaceutical distributor, from Blackstone for approximat... Lee Han-soo 2024-04-22 4:17 PM

Pharma Palmoplantar pustulosis patients pin hope on Skyrizi’s approval Skyrizi (risankizumab) has emerged as a new option for treating palmoplantar pustulosis (PPP), a condition characterized by pustules, exfoliation, and red patches on the palms of t... Kim Chan-hyuk 2024-04-22 4:38 PM

Pharma Bayer Korea launches plogging campaign to celebrate Earth Day In alignment with Earth Day, an annual event on April 22, Bayer Korea began its annual "Glück for Green" plogging campaign, an initiative designed to foster sustainable practices a... Lee Han-soo 2024-04-22 5:01 PM

Device/ICT Canon Medical installs AI-backed low-dose radiation CT simulation at Yeungnam... Canon Medical Systems Korea said it installed Aquilion Exceed LB, a state-of-the-art low-dose radiation CT (computed tomography) simulation machine, at Yeungnam University Medical ... Korea Biomedical Review 2024-04-22 2:42 PM

Device/ICT Plasmapp to supply plasma sterilizer to Osstem Implant Plasmapp, a bioplasma deep-tech company, said Monday that it had signed a contract to supply plasma sterilizers to Osstem Implant.Following signing contracts with large global dist... Korea Biomedical Review 2024-04-22 2:57 PM

Device/ICT Boston Scientific launches intragastric appetite suppression balloon 'BIB System' with coverage Boston Scientific said Monday that it has released the BIB System, a balloon for suppressing appetite in the stomach that can help obese patients lose weight, with insurance covera... Korea Biomedical Review 2024-04-22 3:20 PM

Hospital ‘Low-dose, off-label prescription of NOACs is a risky, misleading choice’ Atrial fibrillation (AF) is one of the most common arrhythmias, with a higher prevalence in older adults. It significantly increases the risk of stroke, and the number of patients ... Kim Chan-hyuk 2024-04-22 1:45 PM

Pharma Polycythemia vera moves a step closer to potential cure Polycythemia vera (PV) is a rare, intractable blood cancer in which a somatic mutation in the bone marrow causes the bone marrow to function abnormally and overproduce red blood ce... Kim Yun-mi 2024-04-22 1:05 PM

Pharma EuBiologics wins green light for phase 1 trial of shingles vaccine On Monday, EuBiologics announced that it obtained regulatory approval to initiate a phase 1 study for its proprietary herpes zoster vaccine, EuHZV. With the endorsement from the Mi... Korea Biomedical Review 2024-04-22 1:31 PM

Policy KPBMA head named to chair Korea's healthcare reform panel The government has nominated Noh Yun-hong, head of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), to chair the presidential Special Committee for Health... Kwak Sung-sun 2024-04-22 11:17 AM

Pharma Regulator approves four generics of oral psoriasis treatment Otezla Four Korean drugmakers have obtained approval for generic versions of Amgen's oral psoriasis treatment, Otezla (apremilast).Daewoong Pharmaceutical, DongKoo Bio&Pharma, Dong-A ST, ... Yang Hyeon-su 2024-04-19 4:27 PM

Pharma Pharma distributor Geo-Young's revenue hits ₩4.4 trillion in 2023 Pharmaceutical distribution company Geo-Young said Friday that its consolidated sales for 2023 reached 4.43 trillion won ($3.21 billion).It marked a 5 percent increase from the pre... Yang Hyeon-su 2024-04-19 4:25 PM

Policy Covid-19 crisis to be downgraded to lowest 'attention' level starting in May The Covid-19 crisis level will be downgraded to the lowest,“attention,” of the four-tier crisis alert system next month, the government said.The Korea Disease Control and Preventio... Kwak Sung-sun 2024-04-19 3:27 PM

Policy Seoul accepts university heads’ demand to lower medical school enrollment increase target Prime Minister Han Duk-soo announced on Friday that the government would accept the request from six national university chiefs to reduce the targeted number of medical school stud... Kim Yoon-mi 2024-04-19 3:56 PM

Device/ICT Korea approves 2 more DTx for vision improvement, respiratory rehabilitation The Ministry of Food and Drug Safety has granted approval to two more digital therapeutic (DTx) devices, developed by Nunaps and Share&Service. These devices, which are the third a... Lee Han-soo 2024-04-19 1:01 PM

Hospital Korean professor named associate editor of European Journal of Preventive Cardiology Professor Jung Mi-hyang of the Department of Cardiology at the Catholic University of Korea St. Mary's Hospital was recently appointed associate editor of the European Journal of P... Kim Chan-hyuk 2024-04-19 4:35 PM

Pharma Secretive drug price negotiations on Lorviqua torture patients The drug price negotiations for Pfizer's third-generation ALK-positive lung cancer drug Lorviqua (lorlatinib) are being done in excessive secrecy, leading to growing frustration am... Kim Yun-mi 2024-04-19 1:18 PM

Pharma Bridge Biotherapeutics advised to continue P2 study for idiopathic pulmonary fibrosis... Bridge Biotherapeutics, a Korean biotech firm, announced positive feedback from the third Independent Data Monitoring Committee (IDMC) meeting to continue the phase 2 clinical tria... Lee Han-soo 2024-04-19 2:01 PM

Hospital Kidney cancer patient group leaders from 21 countries raise awareness and share... The International Kidney Cancer Coalition (IKCC)’s International Conference 2024 wrapped up its three-day event in Incheon, Korea, on Tuesday. About 60 kidney cancer patient group ... You Ji-young 2024-04-19 11:12 AM

Policy Nurses may benefit from law that lessens penalties for medical accidents The government said Thursday that it would consider including nurses as the beneficiaries of the Special Act on Handling Medical Accidents.Officials said there is no problem in inc... Kwak Sung-sun 2024-04-19 1:08 PM

Device/ICT 3Bigs enters distribution agreement with UAE firm 3Bigs, a Korean company specializing in bio big data-based health management solutions, said it entered a distribution partnership with Neo-Science, a bio-health enterprise located... Lee Han-soo 2024-04-19 11:38 AM

Hospital Government considers expanding treatment options for Korean neuroendocrine tumor... Koreans with neuroendocrine tumors have been forced to leave for overseas treatment due to the restriction on the number of domestic treatments -- four reimbursed and two non-reimb... Kim Kyoung-Won 2024-04-18 4:22 PM

Policy Controversy erupts over alleged government hurdles for J-1 visas for Korean trainee... After some doctors claimed that the government had not issued the Statement of Need for J-1 visas to those planning to train in U.S. hospitals, government officials said such claim... Kim Ju-yeon 2024-04-18 1:32 PM

Pharma HLB opens new office in Boston's Cambridge Innovation Center to bolster international... HLB said it opened a new office in the Cambridge Innovation Center (CIC) in Boston, U.S. to bolster the collaboration and communication between HLB and its U.S. subsidiaries, such ... Lee Han-soo 2024-04-18 4:11 PM

Pharma Hanmi Pharm's novel drug receives INN name 'efpegerglucagon' for treating... The International Nonproprietary Name (INN) of LAPS Glucagon analog (code name HM15136), which Hanmi Pharm is developing as an innovative new drug for treating congenital hyperinsu... Yang Hyeon-su 2024-04-18 3:25 PM

Bio SK biopharmaceuticals inks $58 million deal to transfer non-narcotic painkiller tech to... SK biopharmaceuticals said Thursday it has signed a technology transfer agreement with a Chinese joint venture company, Ignis Therapeutics, for a non-narcotic pain treatment candid... Kim Chan-hyuk 2024-04-18 3:05 PM

Pharma Handok and Swedish Orphan Biovitrum launch joint venture in Korea Handok and Swedish Orphan Biovitrum (Sobi) said they have officially inaugurated their Korean joint venture, Handok-Sobi.Sobi is a global biopharmaceutical company specializing in ... Lee Han-soo 2024-04-18 2:48 PM

Pharma GC Cell’s US affiliate initiates 1st patient dosing for lupus nephritis study GC Cell said its U.S. affiliate Artiva Biotherapeutics has begun administering the first dose to a participant in a phase 1 clinical trial. This trial investigates the combination ... Lee Han-soo 2024-04-18 2:04 PM

Policy Keytruda’s coverage expansion effectively ‘shelved’ The Cancer Disease Review Committee (CDRC) of the Health Insurance Review and Assessment Service (HIRA) has once again deferred its decision on expanding coverage for Keytruda (pem... Kim Yun-mi 2024-04-18 1:55 PM

Pharma Celltrion launches Remsima SC in Denmark Celltrion said it has been awarded the national tender for the world's only infliximab subcutaneous (SC) formulation, Remsima SC, in Denmark, a key Nordic market. Under the agreeme... Korea Biomedical Review 2024-04-18 11:18 AM

Device/ICT Coreline Soft begins non-reimbursed billing for AVIEW NeuroCAD brain CT analysis solution Coreline Soft, a Korean medical AI company, said Thursday that the National Evidence-based Healthcare Collaborating Agency (NECA) has completed “notifying innovative medical techno... Korea Biomedical Review 2024-04-18 11:03 AM

Policy Why does Korea lag behind Japan and Taiwan in long-term management of Covid-19? Almost one year has passed since the World Health Organization (WHO) declared the lifting of a Public Health Emergency of International Concern (PHEIC), but is Korea building a lon... Kim Yun-mi 2024-04-17 11:16 AM

Bio Celltrion announces additional buyback and retirement of its shares Celltrion announced its decision to further buy back and retire its own shares as part of its ongoing efforts to stabilize its stock price and enhance shareholder value.The company... Lee Han-soo 2024-04-17 4:08 PM

Life science Generative AI, top investment priority for 62% of healthcare CEOs: KHIDI report Generative AI has become a top investment priority for 62 percent of CEOs who manage life science companies.According to a report released by the Korea Health Industry Development ... Yang Hyeon-su 2024-04-17 2:34 PM

Policy 'Over 8,000 med students should take classes together, instead of current 3,000' President Yoon Suk Yeol's announcement to push for increasing the medical school enrollment quota and healthcare reform, even after the crushing defeat in the 22nd general election... Kim Eun-young 2024-04-17 3:12 PM

Pharma 'Bowel cleanser pill Orafang is safe for people over 70’ A clinical study has shown that Orafang tablets are safe for people in their 40s and 50s and for the very elderly aged 70 or more.Pharmbio Korea said Tuesday that it presented clin... Kim Chan-hyuk 2024-04-17 4:18 PM

Pharma BNC Korea secures rights for Danish firm’s Alzheimer's and Parkinson's treatments BNC Korea said it secured exclusive distribution rights in five Asian countries for Danish biotech firm Kariya's KP405 and KP404, both Alzheimer's and Parkinson's drug candidates t... Lee Han-soo 2024-04-17 2:19 PM

Hospital Gut microbiome types decide autism spectrum’s severity A new study is drawing attention by claiming that the types of intestinal microorganisms determine the severity of the autism spectrum.Autism spectrum disorder (ASD) is a complex d... Kwak Sung-sun 2024-04-17 4:12 PM

Hospital World Medical Association empowers Korean med students to confront healthcare realities Executives of the World Medical Association (WMA) executives directly answered questions from Korean medical students who said they wanted to change the dark reality of Korean heal... Koh Jung Min 2024-04-17 10:39 AM

Hospital Korean, US researchers develop dual fluorescence imaging technique for... A research team at Korea University Guro Hospital (KUGH) and Harvard Medical School has developed the "world’s first" dual fluorescence imaging technique for precision lung cancer ... Lee Han-soo 2024-04-17 11:05 AM

Pharma Tagrisso-chemo combo expands indication for 1st-line NSCLC treatment AstraZeneca Korea's Tagrisso (osimertinib) has expanded its indication to include the first-line treatment of EGFR-mutated non-squamous NSCLC.The Ministry of Food and Drug Safety o... Kim Chan-hyuk 2024-04-17 10:43 AM

상단영역

본문영역